TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson’s Disease

Transforming growth factor-β1 acts via TβR-I on microglia to protect against MPP+-induced dopaminergic neuronal loss

(2016) Zhan Liu et al.   BRAIN BEHAVIOR AND IMMUNITY

TGFβ1 inhibits IFNγ-mediated microglia activation and protects mDA neurons from IFNγ-driven neurotoxicity

(2015) Xiaolai Zhou et al.   JOURNAL OF NEUROCHEMISTRY

Enriched rat primary ventral mesencephalic neurons as an in-vitro culture model

(2015) Venkata S. Bollimpelli et al.   NEUROREPORT

Protection of TGF-β1 against Neuroinflammation and Neurodegeneration in Aβ1–42-Induced Alzheimer’s Disease Model Rats

(2015) Jia-Hui Chen et al.   PLoS One

Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease

(2014) Eunju Leem et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

(2014) Marco Prinz et al.   NATURE REVIEWS NEUROSCIENCE

Environmental Toxins and Parkinson's Disease

(2013) Samuel M. Goldman   Annual Review of Pharmacology and Toxicology

LPS antagonism of TGF-β signaling results in prolonged survival and activation of rat primary microglia

(2013) Kendall Mitchell et al.   JOURNAL OF NEUROCHEMISTRY

MHCII Is Required for  -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

(2013) A. S. Harms et al.   JOURNAL OF NEUROSCIENCE

Identification of a unique TGF-β–dependent molecular and functional signature in microglia

(2013) Oleg Butovsky et al.   NATURE NEUROSCIENCE

Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats

(2013) M.D.A. Teixeira et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress

(2012) Eun S. Park et al.   BRAIN RESEARCH BULLETIN

Distribution of microglia in the postnatal murine nigrostriatal system

(2012) Ahmed Sharaf et al.   CELL AND TISSUE RESEARCH

TGF-β signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment

(2012) Shai Abutbul et al.   GLIA

Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro

(2012) Björn Spittau et al.   GLIA

TGFβ signalling plays an important role in IL4-induced alternative activation of microglia

(2012) Xiaolai Zhou et al.   Journal of Neuroinflammation

Transforming growth factor-β stimulates β amyloid uptake by microglia through Smad3-dependent mechanisms

(2012) Juan E. Tichauer et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System

(2012) Julie Bournival et al.   Oxidative Medicine and Cellular Longevity

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

(2009) Etienne C Hirsch et al.   LANCET NEUROLOGY

NEW evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease

(2009) Sun Shan et al.   NEUROBIOLOGY OF AGING

Formyl-methionyl-leucyl-phenylalanine–Induced Dopaminergic Neurotoxicity via Microglial Activation: A Mediator between Peripheral Infection and Neurodegeneration?

(2008) Xi Gao et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Neuroinflammation and Oxidation/Nitration of  -Synuclein Linked to Dopaminergic Neurodegeneration

(2008) H.-M. Gao et al.   JOURNAL OF NEUROSCIENCE

Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo

(2008) Cheng-Fang Huang et al.   Neuroscience Bulletin

Glial reactions in Parkinson's disease

(2007) Patrick L. McGeer et al.   MOVEMENT DISORDERS